According to the report published by Allied Market Research, the Global Direct Fed Microbial Market garnered $980 million in 2018, and is expected to generate $1.77 billion by 2026, registering a CAGR of 7.5% from 2019 to 2026. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenario.
Direct-fed microbial contains live bacterial strains that help in the growth and development of animals. These beneficial organisms are replacing the use of antibiotics. However, due to the risk of development of antimicrobial-resistant organisms, the use of antibiotics as growth promoters for animal production has been banned. The administration of direct-fed microbial help to enhance the meat and milk production in animals such as cattle and poultry. In addition, these products modulate the immune response of animals and inhibit the growth of pathogenic organisms in the gastrointestinal tract of animals.
Increase in demand for meat & milk and rise in need for probiotics to save overall costs drive the growth of the global direct fed microbial market. However, surge in production cost hinders the market growth. On the other hand, increase in concerns related to the usage of antibiotics for animals create new opportunities in the coming years.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6494
Covid-19 scenario:
- Coronaviruses are zoonotic, which implies that they are transmitted between animals and people. Therefore, livestock owners are more conscious during the coronavirus pandemic, which in turn, increased the demand for direct fed microbial supplements.
- Moreover, the animal feed or animal medicines comes under the essential services category, therefore the supply chain and manufacturing activities have been impacted to very less extent during the Covid-19 outbreak.
- The report offers a detailed segmentation of the global direct fed microbial market based on product type, livestock, and region.
Based on product type, the majority of share was contributed by the lactic acid bacteria segment. It accounted for more than three-fifths of the total share in 2018, and is estimated to maintain its lead position during the forecast period. Furthermore, the same segment is anticipated to grow at the highest CAGR of 7.9% during the forecast period. The research also discusses segments including bacillus and others.
Based on livestock, the majority of share was contributed by the poultry segment, accounting for nearly one-third of the total share in 2018, and is expected to maintain its dominance by 2026. In addition, the same segment is estimated to portray the highest CAGR of 8.5% from 2019 to 2026. The report also analyzes segments including swine, ruminants aquatic animals, and others.
Based on region, North America will maintain its dominance throughout the forecast period and contributed the majority share in 2018, which is more than one-third of the total market share. However, Asia-Pacific is projected to grow at the largest CAGR of 8.1% during the forecast period.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6494
The market report provides an in-depth analysis of the major market players such as Koninklijke DSM N. V, Archer-Daniels-Midland Company, Bio-Vet, E. I. Du Pont De Nemours And Company, CHR. Hansen A/S, Kemin Industries, Inc., Novozymes A/S, Evonik Industries Ag, BASF SE (BASF Corporation), and Adisseo.
Key Findings of the Study:
- Lactic acid bacteriaoccupied more than half share of the global direct fed microbial market in 2018.
- The poultry segment in livestock segment is anticipated to grow with the highest CAGR throughout the forecast period.
- The swine segment in livestock accounted for one-third share of the market in 2018.
- Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/